References

CSACI Guidelines for the Ethical, Evidence‐Based and Patient‐Oriented Clinical Practice of Oral Immunotherapy in IgE‐Mediated Food Allergy

2020 · External reference

EAACI Guidelines on the Management of IgE‐Mediated Food Allergy

10.1111/all.16345 · 2025 · External reference

Food Oral Immunotherapy

10.1186/s13223-025-00948-5 · 2025 · External reference

Efficacy and Safety of Oral Immunotherapy in Children Aged 1‐3 Years With Peanut Allergy (The Immune Tolerance Network IMPACT Trial): A Randomised Placebo‐Controlled Study

10.1016/s0140-6736(21)02390-4 · 2022 · External reference

AR101 Oral Immunotherapy for Peanut Allergy

10.1056/nejmoa1812856 · 2018 · External reference

Efficacy and Safety of Food Allergy Oral Immunotherapy in Adults

10.1111/all.15537 · 2023 · External reference

Allergen Immunotherapy for IgE‐Mediated Food Allergy: A Systematic Review and Meta‐Analysis

10.1111/all.13124 · 2017 · External reference

Unresolved reference

External reference

Beyond T‐Cells: Functional Characterization of CTLA‐4 Expression in Immune and Non‐Immune Cell Types

10.3389/fimmu.2020.608024 · 2020 · External reference

A Review on Applications of Abatacept in Systemic Rheumatic Diseases

10.1016/j.intimp.2021.107612 · 2021 · External reference

Confusing Signals: Recent Progress in CTLA‐4 Biology

10.1016/j.it.2014.12.001 · 2015 · External reference

A Randomized Controlled Trial to Evaluate Inhibition of T‐Cell Costimulation in Allergen‐Induced Airway Inflammation

10.1164/rccm.201207-1205oc · 2013 · External reference

Cytotoxic T Lymphocyte Antigen 4‐Immunoglobulin G Is a Potent Adjuvant for Experimental Allergen Immunotherapy

10.1111/cei.12041 · 2013 · External reference

The CD28/CTLA‐4‐B7 Signaling Pathway Is Involved in Both Allergic Sensitization and Tolerance Induction to Orally Administered Peanut Proteins

10.4049/jimmunol.178.11.6894 · 2007 · External reference

Abatacept to Induce Remission of Peanut Allergy During Oral Immunotherapy (ATARI): Protocol for a Phase 2a Randomized Controlled Trial

10.3389/fmed.2023.1198173 · 2023 · External reference

Standardizing Double‐Blind, Placebo‐Controlled Oral Food Challenges: American Academy of Allergy, Asthma & Immunology‐European Academy of Allergy and Clinical Immunology PRACTALL Consensus Report

10.1016/j.jaci.2012.10.017 · 2012 · External reference

10.1137/1.9780898718454

10.1137/1.9780898718454 · 2003 · External reference

Unresolved reference

External reference

Mechanisms of Food Allergy

10.1111/j.1399-3038.2008.00847.x · 2009 · External reference

The T Lymphocyte in Food‐Allergy Disorders

10.1097/00130832-200306000-00008 · 2003 · External reference

T Lymphocytes in Food Allergy: Overview of an Intricate Network of Circulating and Organ‐Resident Cells

10.1034/j.1399-3038.2002.01015.x · 2002 · External reference

Peanut Oral Immunotherapy Transiently Expands Circulating Ara h 2‐Specific B Cells With a Homologous Repertoire in Unrelated Subjects

10.1016/j.jaci.2015.03.026 · 2015 · External reference

Lifelong Memory Responses Perpetuate Humoral T(H)2 Immunity and Anaphylaxis in Food Allergy

10.1016/j.jaci.2017.01.018 · 2017 · External reference

Sustained Successful Peanut Oral Immunotherapy Associated With Low Basophil Activation and Peanut‐Specific IgE

10.1016/j.jaci.2019.10.038 · 2020 · External reference

Peanut and Arah2 Specific Immunoglobulin E Is Predictive of Sustained Unresponsiveness Following Peanut Oral Immunotherapy

10.1016/j.jaci.2015.12.765 · 2016 · External reference

Murine CTLA4‐IgG Treatment Inhibits Airway Eosinophilia and Hyperresponsiveness and Attenuates IgE Upregulation in a Murine Model of Allergic Asthma

10.1165/ajrcmb.17.3.2679 · 1997 · External reference

Interrupting CD28 Costimulation Before Antigen Rechallenge Affects CD8(+) T‐Cell Expansion and Effector Functions During Secondary Response in Mice

10.1002/eji.201546232 · 2016 · External reference

Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy

10.1111/all.16420 · 2025 · External reference

Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study)

2022 · External reference

Sustained Unresponsiveness to Peanut in Subjects Who Have Completed Peanut Oral Immunotherapy

10.1016/j.jaci.2013.11.007 · 2014 · External reference

Induction of Sustained Unresponsiveness After Egg Oral Immunotherapy Compared to Baked Egg Therapy in Children With Egg Allergy

10.1016/j.jaci.2020.05.040 · 2020 · External reference

Oral Immunotherapy in Peanut‐Allergic Adults Using Real‐World Materials

10.1111/all.16493 · 2025 · External reference

Component‐Resolved Analysis of IgA, IgE, and IgG4 During Egg OIT Identifies Markers Associated With Sustained Unresponsiveness

10.1111/all.12895 · 2016 · External reference

Long‐Term Treatment With Egg Oral Immunotherapy Enhances Sustained Unresponsiveness That Persists After Cessation of Therapy

10.1016/j.jaci.2015.12.1316 · 2016 · External reference

Safety Profile of Abatacept in Rheumatoid Arthritis: A Review

10.1016/j.clinthera.2010.10.011 · 2010 · External reference

Efficacy and Safety of Abatacept in Biologic‐naïve Patients With Active Rheumatoid Arthritis by Background Methotrexate Dose: Post Hoc Analysis of a Randomized, Placebo‐Controlled, Phase 4 Study

10.1093/mr/roab029 · 2022 · External reference

Efficacy and Safety of Oral Immunotherapy for Peanut, Cow's Milk, and Hen's Egg Allergy: A Systematic Review of Randomized Controlled Trials

10.1002/clt2.12268 · 2023 · External reference

Safety of Peanut (Arachis Hypogaea) Allergen Powder‐Dnfp in Children and Teenagers With Peanut Allergy: Pooled Summary of Phase 3 and Extension Trials

10.1016/j.jaci.2021.12.780 · 2022 · External reference

Onset of Eosinophilic Esophagitis During a Clinical Trial Program of Oral Immunotherapy for Peanut Allergy

10.1016/j.jaip.2021.07.048 · 2021 · External reference

Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy

10.1016/j.cgh.2020.05.019 · 2021 · External reference